SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
580YM - oncodoc Re: Gleevec for CA,,, 24 minutes ago I usually advise agaiIRWIN JAMES FRANKEL-2/17/2011
579YM - I-rat Gleevec for CA,,, 12 minutes ago Sorry for posting so much,,IRWIN JAMES FRANKEL-2/17/2011
578Fair enough. But when you throw in stable disease - only one guy had disease prIRWIN JAMES FRANKEL-2/17/2011
577I'd feel better if they had broken down the Partial Response and Complete Rebmaz001-2/17/2011
576YM I-rat Amazing so far. 85% showed partial or complete bone met resolution. AnIRWIN JAMES FRANKEL-2/17/2011
575Poster exelixis.comIRWIN JAMES FRANKEL-2/17/2011
574Conference call at 6:30PM ET tonight... These results look exceptionally good toIan@SI-2/17/2011
573Here's a more recent publication along the same lines (full text is freely aBiomaven-2/16/2011
572YM - earnie This is an interesting find. First, just for clarification, this isIRWIN JAMES FRANKEL-2/16/2011
571YM - intelligent rat A thought about the PSA levels not correlating with tumor IRWIN JAMES FRANKEL12/15/2011
570Link is now working. gucasymposium.org Data is old predating the releases in DIRWIN JAMES FRANKEL-2/15/2011
569Abstract page: gucasymposium.org But I got "content not found" when IRWIN JAMES FRANKEL-2/15/2011
568Abstract available in less than 15 minutes at ASCO's website. Reminder: ExeIan@SI-2/15/2011
567Seeking Alpha Exelixis: A Successful Development Stage Biotech Firm Small deveIRWIN JAMES FRANKEL-2/14/2011
566IH - Biomaven responding to DD: DD>> To date, I don’t think EXEL has presIRWIN JAMES FRANKEL-2/14/2011
565YM - intelligent rat And word continues to spread,,,, 14-Feb-11 05:10 pm IRWIN JAMES FRANKEL-2/14/2011
564YM - earnie Bio CEO Summary 5 minutes ago First, the abstract tomorrow IRWIN JAMES FRANKEL-2/14/2011
563I've been wrong too often to have any confidence in my judgment (I thought Ctom pope-2/13/2011
562XL-184 in MTC explanation. This is the indication in which XL184 is most advancIRWIN JAMES FRANKEL-2/13/2011
561delete - dupIRWIN JAMES FRANKEL-2/12/2011
560YM- Oncodoc - I suppose a late breaker is a possibility, however a late breakeIRWIN JAMES FRANKEL-2/12/2011
559YM - wiscman Monday......BIO & CEO investor conf 11:30am EST.....CEO will bIRWIN JAMES FRANKEL-2/11/2011
558I personally would appreciate your copies and have utmost confidence in your filBiomaven12/11/2011
557I would be glad to copy the better posts here if that was desirable - it could sIRWIN JAMES FRANKEL22/11/2011
556>>Earnie, oncodoc, and joeflow77 are a few of the fine posters. I so hateBiomaven-2/9/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News